A System to Help With Freezing of Gait in Parkinson's Patients
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorBarron Associates, Inc.
About this trial
The goal of this clinical trial is to learn if the ParkinSense system, a customizable, multimodal, and adaptable cueing system, can assist with freezing of gait (FOG) in patients with Parkinson's disease. The main question it aims to answer is: is the percent of time spent frozen reduced when using the system compared to not using the system? Participants will be asked to take part in a single-visit laboratory study where they will wear the system in a controlled environment, followed by a two weeks of home use.
Eligibility criteria
Qualifiers
Confirmed diagnosis of idiopathic Parkinson's Disease
Prior identified presence of Freezing of Gait
Ability to ambulate;
Montreal Cognitive Assessment (MOCA) MOCA questionnaire score >=21.
Disqualifiers
Peripheral neuropathy
Dementia
Severe gait abnormalities not related to Parkinson's Disease.
Trial design
Treatments tested in this trial
- ParkinSense System
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Barron Associates, Inc.
Lead sponsor
National Institute on Aging (NIA)
Collaborator
University of Virginia
Collaborator
Source ClinicalTrials.gov